AIS
SAGE

Accurate Investment Solutions’s Sage Therapeutics SAGE Stock Holding History

Accurate Investment Solutions’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-30
Closed -$5K – 489
2018
Q2 		$5K Hold
30
– – ﹤0.01% 346
2018
Q1 		$5K Hold
30
– – ﹤0.01% 333
2017
Q4 		$5K Buy
+30
New +$2.91K ﹤0.01% 325

Other funds holding SAGE

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Accurate Investment Solutions's SAGE Position: Q3 2018 in Review

Accurate Investment Solutions sold out of Sage Therapeutics (SAGE) in Q3 2018, closing a stake of 30 shares — an estimated $5K sold.

Accurate Investment Solutions first reported a position in SAGE in Q4 2017 and held it in 3 quarters. The position peaked at $5K in Q2 2018. 275 funds tracked by Wall St. Rank hold SAGE as of Q3 2018.

  • Accurate Investment Solutions reported no remaining Sage Therapeutics position as of Q3 2018 after selling out during the quarter.
  • Accurate Investment Solutions sold 30 Sage Therapeutics shares in Q3 2018, an estimated $5K.
  • Accurate Investment Solutions first reported a position in Sage Therapeutics in Q4 2017 and held it in 3 quarters.
  • Accurate Investment Solutions's Sage Therapeutics position peaked at $5K in Q2 2018.
  • 275 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2018.

Based on Accurate Investment Solutions's 13F filing for Q3 2018, filed 5 Oct 2018.